CN
EN
Home
About Us
Overview
Company History
Core Team
Virtual Exhibit
Science
NK (Natural Killer) Cells
NK Receptor & Tumor Recognition
NK Cells and CTL
History of NK Cell and Cellular Therapy
Publications
Technology
ABCDE-NK
®
Strategy
Precision Strategy
Advantages of PB-NK Cells
Synthetic NK Cells
Full Human Mice
Pipeline
Pipeline
Case Report
News
Press Releases
Media Report
Careers
Vision
Working at NK CellTech
Career Opportunity
Contact
Our Location
Contact
News
Share our moments with you all the time
Home
>
News
>
Coming Soon
Coming Soon
2022-10-01
share:
Prev:
Coming Soon
Next:
NK CellTech Raises Over 100 Million CNY in Series A Financing Round, Becoming a Strong Dark Horse in the NK Cell Immunotherapy Field
Back to list
News
Press Releases
Media Report
Recommended news
2024-01-22
NK CellTech Announces FDA Clearance for Clinical Trial of NK010
2022-06-02
NK CellTech Chairman Zhigang Tian elected member of Academia Europaea
© Copyright by CSPC All rights reserved.
ICP备字:沪ICP备2022013361号-1
Legal statement
Privacy Policy
Terms Of Use
HOME
About Us
Overview
Company History
Core Team
Virtual Exhibit
Science
NK Cells
NK Receptor & Tumor Recognition
NK cells and CTL
History of NK Cell and Cellular Therapy
Publications
Technology
ABCDE-NK
®
Strategy
Precision Strategy
Advantages of PB-NK Cells
Synthetic NK Cells
Full Human Mice
Pipeline
News
Careers
Contact